Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

Also called NCT01862978

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01862978
Other papers using this trial's data
  • The safety and efficacy of Heparin and Nadroparin compared to placebo in acute ischemic stroke - pilot study Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2016-12 DOI, PubMed 27646496

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Slovakia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01862978. Randomized; quadruple masking; primary purpose treatment. Start 2013-05 (registry gives no type); primary completion 2015-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke
Acronym
Heparinas
Condition
Acute Ischemic Stroke
Intervention (Drug)
Heparin
Intervention (Drug)
Nadroparin
Intervention (Drug)
Placebo
Lead sponsor
University Hospital, Martin (class: other)

Record details

Record id
cardio:ct-nct01862978
Content hash
5671fdaaf80f12a7a0c30eeba16ef9167c7e87a091615e9fc53acfcbf1db7607